Walleye Trading’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2M Sell
1,253,400
-440,500
-26% -$11.7M 0.06% 325
2025
Q4
$42.2M Sell
1,693,900
-222,700
-12% -$5.62M 0.06% 342
2025
Q3
$48.8M Sell
1,916,600
-22,800
-1% -$563K 0.07% 269
2025
Q2
$47M Sell
1,939,400
-254,600
-12% -$5.94M 0.09% 243
2025
Q1
$55.6M Buy
2,194,000
+944,100
+76% +$24.7M 0.13% 141
2024
Q4
$33.2M Sell
1,249,900
-109,000
-8% -$2.96M 0.07% 306
2024
Q3
$39.3M Buy
1,358,900
+281,900
+26% +$8.22M 0.08% 253
2024
Q2
$30.1M Sell
1,077,000
-45,200
-4% -$1.24M 0.07% 288
2024
Q1
$31.1M Buy
1,122,200
+532,800
+90% +$14.8M 0.07% 285
2023
Q4
$17M Buy
589,400
+169,900
+41% +$5.14M 0.04% 526
2023
Q3
$13.9M Buy
419,500
+8,100
+2% +$286K 0.04% 517
2023
Q2
$15.1M Sell
411,400
-661,700
-62% -$25.8M 0.05% 401
2023
Q1
$43.8M Sell
1,073,100
-382,400
-26% -$16.5M 0.1% 170
2022
Q4
$74.6M Sell
1,455,500
-35,800
-2% -$1.72M 0.21% 61
2022
Q3
$65.3M Buy
1,491,300
+356,200
+31% +$17.3M 0.2% 67
2022
Q2
$59.5M Buy
1,135,100
+684,400
+152% +$34.9M 0.19% 63
2022
Q1
$23.3M Sell
450,700
-184,100
-29% -$9.55M 0.07% 301
2021
Q4
$37.5M Buy
634,800
+36,300
+6% +$1.8M 0.12% 152
2021
Q3
$25.7M Buy
598,500
+376,600
+170% +$16.7M 0.09% 210
2021
Q2
$8.69M Buy
221,900
+68,600
+45% +$2.67M 0.03% 500
2021
Q1
$5.55M Buy
153,300
+55,100
+56% +$1.96M 0.02% 593
2020
Q4
$3.62M Buy
98,200
+9,980
+11% +$366K 0.02% 946
2020
Q3
$3.07M Sell
88,220
-102,870
-54% -$3.61M 0.02% 852
2020
Q2
$5.93M Buy
191,090
+33,095
+21% +$1.12M 0.04% 453
2020
Q1
$4.89M Buy
157,995
+101,290
+179% +$3.45M 0.04% 388
2019
Q4
$2.11M Buy
56,705
+21,818
+63% +$777K 0.01% 1192
2019
Q3
$1.19M Buy
34,887
+15,283
+78% +$556K 0.01% 1466
2019
Q2
$806K Sell
19,604
-5,270
-21% -$209K 0.01% 1777
2019
Q1
$1M Sell
24,874
-32,042
-56% -$1.28M 0.01% 1659
2018
Q4
$2.36M Sell
56,916
-22,345
-28% -$928K 0.02% 944
2018
Q3
$3.31M Sell
79,261
-128,693
-62% -$4.95M 0.02% 917
2018
Q2
$7.16M Buy
207,954
+106,665
+105% +$3.65M 0.04% 428
2018
Q1
$3.41M Sell
101,289
-402,523
-80% -$13.8M 0.02% 765
2017
Q4
$17.3K Buy
503,812
+14,756
+3% +$503K 0.08% 163
2017
Q3
$16.6K Sell
489,056
-355,830
-42% -$11.4M 0.08% 167
2017
Q2
$26.9K Buy
844,886
+262,867
+45% +$8.29M 0.17% 73
2017
Q1
$18.9K Buy
582,019
+422,022
+264% +$13.3M 0.13% 97
2016
Q4
$4.93M Sell
159,997
-15,810
-9% -$483K 0.03% 450
2016
Q3
$5.65M Sell
175,807
-404,736
-70% -$13.5M 0.04% 379
2016
Q2
$19.4M Sell
580,543
-799,775
-58% -$25.5M 0.13% 83
2016
Q1
$38.8M Buy
1,380,318
+252,749
+22% +$7.22M 0.34% 27
2015
Q4
$34.5M Buy
1,127,569
+1,083,617
+2,465% +$34.1M 0.34% 35
2015
Q3
$1.31M Sell
43,952
-514,668
-92% -$16.5M 0.01% 893
2015
Q2
$17.8M Buy
558,620
+139,971
+33% +$4.56M 0.18% 78
2015
Q1
$13.8M Buy
418,649
+348,558
+497% +$11.1M 0.14% 107
2014
Q4
$2.07M Sell
70,091
-37,839
-35% -$1.08M 0.02% 669
2014
Q3
$3.03M Sell
107,930
-34,782
-24% -$976K 0.04% 276
2014
Q2
$4.02K Buy
142,712
+58,076
+69% +$1.66M 0.05% 182
2014
Q1
$2.58K Buy
84,636
+9,170
+12% +$273K 0.04% 341
2013
Q4
$2.19M Sell
75,466
-199,523
-73% -$5.81M 0.02% 634
2013
Q3
$7.5M Buy
274,989
+191,196
+228% +$5.2M 0.08% 186
2013
Q2
$2.23M Buy
+83,793
New +$2.32M 0.02% 531

Other funds holding PFE

Walleye Trading's PFE Position: Q1 2026 in Review

Walleye Trading opened a new position in Pfizer (PFE) in Q1 2026: 223,265 shares worth $6.27M. The stake represents 0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: Walleye Trading previously reported a position in PFE as recently as Q3 2025.

Walleye Trading first reported a position in PFE in Q4 2013 and has held it in 38 quarters since. The position peaked at $38.3M in Q3 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Walleye Trading held 223,265 shares of Pfizer worth $6.27M as of Q1 2026.
  • Pfizer was a new Walleye Trading position in Q1 2026.
  • Pfizer made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #1013 holding.
  • Walleye Trading first reported a position in Pfizer in Q4 2013 and has held it in 38 quarters since.
  • Walleye Trading's Pfizer position peaked at $38.3M in Q3 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.